FDA’s Califf: Expect to see more RWE-based regulatory decisions
Regulatory NewsFerdous Al-Faruque
APIsBiologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsDiagnostics/IVDsMedical DevicesNorth AmericaNutritional/Natural HealthOTCOtherPharmaceuticalsRegulatory Intelligence/Policy